There was no strong evidence that any aPL other than LA significantly associated with arterial thrombosis. factor for any [2.00 (1.22, 3.3),P= 0.0065] Givinostat and venous [2.8 (1.42, 5.51),P= 0.0029] thrombosis. Only anti-2-glycoprotein I IgA appeared to add significant risk to any [1.73 (1.04, 2.88),P= 0.0362] and venous [2.27 (1.13, 4.59),P= 0.0218] thrombosis among those […]